Trial Profile
A phase 2 trial of ATX-UV-3 in the patients with uveitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2018
Price :
$35
*
At a glance
- Drugs ATX UV 3 (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- 05 Nov 2018 New trial record